oc697vot.blogspot.com
The company reported $92.4 millio n in revenue for the quarter endinhgApril 30, up 2 percent from the same perior last year. It earned $11 million in net income, or 33 centz per diluted share, during the second quarter, compareds with $9.2 million, or 28 cents per dilutecd share, during the second quarter of last Analysts polled by expected the companyu to earn 29 cents per shareand $89 million in Martek (NASDAQ: MATK) sells nutritional oils derivede from algae that are used in infant formula, dietary supplementa and food products such as yogurt and juice. Saleas of its nutritional supplements to the nursing market rose to arecord $9.8 million.
But the compang warned that its infant formula sales in the thirde and fourth quarters couls drop as retailers trim their inventories of the The company anticipates that infantr formula revenue will grow in fiscal 2010 as a resulr of strong demand for infant formula products containing its nutritional oils DHAand ARA. The Omega-e fatty acids are believed to play an important role in brain andeye development.
study that could show that Martek’ds DHA can slow the progressionof Alzheimer’s
ไม่มีความคิดเห็น:
แสดงความคิดเห็น